Company profile
UK company 03751674, incorporated on 14 April 1999.
Astex Oncology and CNS Drug Discovery & Development
Astex Therapeutics Limited is a UK company with status Active founded in 1999 based in East of England.
Company number 03751674
Updated 07 Jul 2026 09:49
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
CS01 | Transaction MzUzNTc2MTQ4OGFkaXF6a2N4
Published 30 Jul 2026 07:42
AP01 | Transaction MzUzNTIwNzAyOWFkaXF6a2N4
Published 28 Jul 2026 13:31
AP01 | Transaction MzUzNTIwNjEzNGFkaXF6a2N4
Published 28 Jul 2026 13:09
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Sep 2023 to 31 Aug 2025
OutSee Limited working with Astex Pharmaceuticals will be unlocking value and insights in non-coding genomic data through the _Nomaly_ approach to support precision medicine for dementia patients. We will be developing new AI to tackle the non-coding part of the genome alongside discovery developed on the protein-coding variation in the genome. Dementia i...
1 Nov 2021 to 30 Apr 2023
The process of discovering and testing new drugs is very expensive and takes a long time. The average cost of discovering a new drug and bringing it to market has tripled since 2010, reaching almost $3bn in 2018\. Current methods for discovering new drugs are unreliable and involve a 'trial-and-error' approach. Pharmaceutical companies want to reduce the ...
